Discovery of Novel Allosteric Modulators Targeting an Extra-Helical Binding Site of GLP-1R Using Structure- and Ligand-Based Virtual Screening.
Allosteric Site
/ drug effects
Animals
Binding Sites
/ drug effects
CHO Cells
Cricetinae
Cricetulus
Drug Delivery Systems
/ methods
Drug Discovery
/ methods
Glucagon
/ administration & dosage
Glucagon-Like Peptide-1 Receptor
/ chemistry
Humans
Ligands
Molecular Docking Simulation
/ methods
Protein Binding
/ drug effects
Protein Structure, Secondary
Protein Structure, Tertiary
GLP-1R
allosteric modulator
drug discovery
molecular docking
virtual screening
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
23 06 2021
23 06 2021
Historique:
received:
26
04
2021
revised:
12
06
2021
accepted:
16
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
23
9
2021
Statut:
epublish
Résumé
Allosteric modulators have emerged with many potential pharmacological advantages as they do not compete the binding of agonist or antagonist to the orthosteric sites but ultimately affect downstream signaling. To identify allosteric modulators targeting an extra-helical binding site of the glucagon-like peptide-1 receptor (GLP-1R) within the membrane environment, the following two computational approaches were applied: structure-based virtual screening with consideration of lipid contacts and ligand-based virtual screening with the maintenance of specific allosteric pocket residue interactions. Verified by radiolabeled ligand binding and cAMP accumulation experiments, two negative allosteric modulators and seven positive allosteric modulators were discovered using structure-based and ligand-based virtual screening methods, respectively. The computational approach presented here could possibly be used to discover allosteric modulators of other G protein-coupled receptors.
Identifiants
pubmed: 34201418
pii: biom11070929
doi: 10.3390/biom11070929
pmc: PMC8301998
pii:
doi:
Substances chimiques
GLP1R protein, human
0
Glucagon-Like Peptide-1 Receptor
0
Ligands
0
Glucagon
9007-92-5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Comput Aided Mol Des. 2019 Nov;33(11):973-981
pubmed: 31758355
J Med Chem. 2020 Mar 12;63(5):2292-2307
pubmed: 31596080
Expert Opin Drug Discov. 2015 May;10(5):449-61
pubmed: 25835573
ACS Omega. 2019 Jan 11;4(1):961-970
pubmed: 31459371
Nat Commun. 2017 Feb 09;8:14335
pubmed: 28181498
Science. 2019 Jun 28;364(6447):1283-1287
pubmed: 31249059
J Med Chem. 2019 Jan 10;62(1):88-127
pubmed: 30106578
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):943-8
pubmed: 17213311
J Phys Chem B. 2010 Jun 17;114(23):7830-43
pubmed: 20496934
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
Nature. 2018 Sep;561(7724):492-497
pubmed: 30209400
J Med Chem. 2011 Dec 8;54(23):8195-206
pubmed: 22007643
Nature. 2017 Jun 8;546(7657):312-315
pubmed: 28514449
Exp Diabetes Res. 2012;2012:709893
pubmed: 22611375
Nat Chem Biol. 2018 Mar;14(3):262-269
pubmed: 29309055
J Med Chem. 2010 Apr 8;53(7):2719-40
pubmed: 20131845
Nat Chem Biol. 2014 Aug;10(8):629-31
pubmed: 24997604
J Chem Inf Model. 2009 Jan;49(1):84-96
pubmed: 19125657
Nat Chem Biol. 2020 Oct;16(10):1105-1110
pubmed: 32690941
J Comput Aided Mol Des. 2013 Mar;27(3):221-34
pubmed: 23579614
Bioinformatics. 2013 Apr 1;29(7):845-54
pubmed: 23407358
Nat Chem Biol. 2019 Dec;15(12):1199-1205
pubmed: 31659318
ACS Chem Biol. 2013 May 17;8(5):1018-26
pubmed: 23485065
Nature. 2013 Jul 25;499(7459):438-43
pubmed: 23863939
ChemMedChem. 2019 Mar 5;14(5):514-521
pubmed: 30609277
J Chem Inf Model. 2007 Jan-Feb;47(1):195-207
pubmed: 17238265
Protein Sci. 2020 Jan;29(1):52-65
pubmed: 31531901
Nat Commun. 2021 Jun 18;12(1):3763
pubmed: 34145245
Nature. 2013 Feb 14;494(7436):185-94
pubmed: 23407534
Drug Discov Today Technol. 2010 Winter;7(4):e203-70
pubmed: 24103800
Cell. 2018 Jan 11;172(1-2):41-54.e19
pubmed: 29249361
Pharmacol Rev. 2016 Oct;68(4):954-1013
pubmed: 27630114
Nature. 2020 Mar;579(7800):609-614
pubmed: 32040955
Elife. 2019 Dec 19;8:
pubmed: 31855179
BMC Res Notes. 2012 Jul 23;5:367
pubmed: 22824207
Chem Sci. 2018 Feb 20;9(12):3192-3199
pubmed: 29732102
Nature. 2020 Jan;577(7790):432-436
pubmed: 31915381
Sci Rep. 2016 Jun 24;6:28288
pubmed: 27339552
Cell. 2020 Feb 20;180(4):655-665.e18
pubmed: 32004463
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5211-6
pubmed: 23479653
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:89-107
pubmed: 31454292
J Chem Theory Comput. 2012 Mar 13;8(3):948-58
pubmed: 26593357
Annu Rev Pharmacol Toxicol. 2013;53:531-56
pubmed: 23140243
Bioorg Med Chem Lett. 2019 Oct 15;29(20):126611
pubmed: 31447084
J Med Chem. 2011 Apr 28;54(8):2529-91
pubmed: 21413808
Nat Med. 2021 Jun;27(6):1079-1087
pubmed: 34127852
J Med Chem. 2004 Mar 25;47(7):1750-9
pubmed: 15027866
Nature. 2016 Apr 25;533(7602):274-7
pubmed: 27111510
Cell Res. 2020 Dec;30(12):1140-1142
pubmed: 32724086
Genomics Proteomics Bioinformatics. 2019 Oct;17(5):478-495
pubmed: 32035227